Pathway Financial Advisers, LLC Laboratory Corp Of America Holdings Transaction History

Pathway Financial Advisers, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 29, 2024	BUY	$209.01 - $232.56 $28,216 - $31,395	135 New	135 $29.6 Million
Q3 2023 Jul 19, 2024	BUY	$201.05 - $221.7 $201 - $221	1 Added 0.75%	135 $27.1 Million
Q1 2023 Jul 19, 2024	SELL	$213.32 - $257.83 $8,532 - $10,313	-40 Reduced 22.99%	134 $30.7 Million
Q4 2022 Jul 19, 2024	BUY	$203.72 - $248.97 $7,945 - $9,709	39 Added 28.89%	174 $41.1 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Pathway Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathway Financial Advisers, LLC with notifications on news.